Hirosaki University Hospital

Hirosaki, Aomori 0368203

0 studies enrolling now · 7 studies all time

What they study most

Atrial Fibrillation, Carcinoma, Transitional Cell, Heart Failure, Heart Failure With Left Bundle Branch Block, NSCLC, Non-small Cell Lung Cancer, Prostate Cancer, Relapsed Small Cell Lung Cancer

Studies at this site

• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer — Running, not enrolling
• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF — Completed
• AdaptResponse Clinical Trial — Completed
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• MultiPoint Pacing™ Post Market Study — Completed